Aligned Genetics, Inc. (KOSDAQ:238120)

Aligned Genetics Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	17,351	15,778	15,215	13,753	11,762	7,957
Other Revenue	-	-	-0	-0	-	-
Revenue	17,351	15,778	15,215	13,753	11,762	7,957
Revenue Growth (YoY)	15.68%	3.70%	10.63%	16.92%	47.82%	2.10%
Cost of Revenue	5,382	4,629	4,556	4,998	4,424	3,425
Gross Profit	11,969	11,148	10,659	8,755	7,338	4,532
Selling, General & Admin	6,146	5,619	5,125	4,287	3,791	3,446
Research & Development	2,465	2,292	1,684	1,079	943.58	816.17
Amortization of Goodwill & Intangibles	20.17	15.7	19.3	21.33	35.46	45.76
Other Operating Expenses	103.5	96.87	84.21	77.31	59.34	35.92
Operating Expenses	9,071	8,369	7,322	5,906	5,159	4,785
Operating Income	2,898	2,780	3,337	2,849	2,179	-253.48
Interest Expense	-65.64	-169.15	-214.88	-165.96	-28.88	-82.83
Interest & Investment Income	227.41	405.32	161.61	168.16	27.71	163.3
Earnings From Equity Investments	29.26	-	-	-	-	-79.28
Currency Exchange Gain (Loss)	991.53	1,530	302.06	17.89	353.05	-255.15
Other Non Operating Income (Expenses)	55.65	33.59	8.09	83.88	-238.9	31.32
EBT Excluding Unusual Items	4,136	4,579	3,594	2,953	2,292	-476.12
Gain (Loss) on Sale of Investments	-331.42	-36.7	-147.75	-510.71	1,507	944.36
Gain (Loss) on Sale of Assets	-0	-	-22.04	-	13.94	-
Pretax Income	3,805	4,542	3,424	2,442	3,813	468.23
Income Tax Expense	61.93	414.26	188.16	109.5	-1,729	-
Net Income	3,743	4,128	3,236	2,333	5,542	468.23
Net Income to Common	3,743	4,128	3,236	2,333	5,542	468.23
Net Income Growth	51.02%	27.57%	38.72%	-57.90%	1083.53%	301.10%
Shares Outstanding (Basic)	14	14	14	14	14	10
Shares Outstanding (Diluted)	14	14	14	14	14	10
Shares Change (YoY)	-1.41%	-	-	-	38.26%	-27.67%
EPS (Basic)	263.93	287.09	225.05	162.23	385.40	45.02
EPS (Diluted)	263.84	287.00	225.00	162.00	385.40	45.00
EPS Growth	53.12%	27.56%	38.89%	-57.97%	756.45%	462.50%
Free Cash Flow	132.61	2,808	1,970	220.98	-3,171	-60.76
Free Cash Flow Per Share	9.35	195.26	137.01	15.37	-220.57	-5.84
Gross Margin	68.98%	70.66%	70.06%	63.66%	62.38%	56.95%
Operating Margin	16.70%	17.62%	21.93%	20.72%	18.52%	-3.19%
Profit Margin	21.57%	26.16%	21.27%	16.96%	47.12%	5.88%
Free Cash Flow Margin	0.76%	17.79%	12.95%	1.61%	-26.96%	-0.76%
EBITDA	3,457	3,355	3,968	3,499	2,718	422.59
EBITDA Margin	19.92%	21.27%	26.08%	25.45%	23.10%	5.31%
D&A For EBITDA	558.59	575.74	631.38	650.38	538.59	676.07
EBIT	2,898	2,780	3,337	2,849	2,179	-253.48
EBIT Margin	16.70%	17.62%	21.93%	20.72%	18.52%	-3.19%
Effective Tax Rate	1.63%	9.12%	5.50%	4.48%	-	-
Advertising Expenses	-	359.22	261.67	243.86	96.94	229.45

Source: S&P Global Market Intelligence. Standard template. Financial Sources.